Refractory pneumonia due to persistent SARS-CoV-2 infection in an immunocompromised host successfully treated with extended course nirmatrelvir/ritonavir

January 21, 2025
Virology
Pathogen:SARS-CoV-2
Infection Type:Respiratory infection
Pathogen Type:RNA viruses

Case Summary

No summary available

DOI: 10.1128/asmcr.00049-24